Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomes
Authors:
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 38 (10) , 797.e15-797.e20
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and managementWorld Journal of Urology, 2018
- Renal Mass and Localized Renal Cancer: AUA GuidelineJournal of Urology, 2017
- Hereditary Renal Cell Carcinoma SyndromesAmerican Journal of Surgical Pathology, 2015
- EAU Guidelines on Renal Cell Carcinoma: 2014 UpdateEuropean Urology, 2015
- Defining Early-Onset Kidney Cancer: Implications for Germline and Somatic Mutation Testing and Clinical ManagementJournal of Clinical Oncology, 2014
- Determination of the Nonlethal Margin Inside the Visible “Ice-Ball” During Percutaneous Cryoablation of Renal TissueCardioVascular and Interventional Radiology, 2012
- Radiological evaluation, management, and surveillance of renal masses in Von Hippel–Lindau diseaseClinical Radiology, 2009
- THE RELATIONSHIP BETWEEN RENAL TUMOR SIZE AND METASTASES IN PATIENTS WITH VON HIPPEL-LINDAU DISEASEJournal of Urology, 2004
- von Hippel-Lindau diseaseThe Lancet, 2003
- RENAL CANCER IN FAMILIES WITH HEREDITARY RENAL CANCER: PROSPECTIVE ANALYSIS OF A TUMOR SIZE THRESHOLD FOR RENAL PARENCHYMAL SPARING SURGERYJournal of Urology, 1999